News
Wojcicki, a co-founder and former CEO of 23andMe, is buying ‘substantially all’ of the company’s assets through a nonprofit.
Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results